new england journal of medicine retatrutide Retatrutide, an Amazing Future for Weight Loss new england journal of medicine

Research published in major metabolic journals shows that total energy expenditure decreases approximately 15% following a 10% reduction in body weight

Meanwhile, 9 in 10 of the respondents from plans with a median of 14,000 enrollees said they were moderately or very concerned about the affordability of GLP-1 therapies for the plan

All policies found in the Superior HealthPlan Clinical Policy Manual apply to Superior HealthPlan members

Check ClinicalTrials.gov and search for retatrutide to see active trials

As patents evolve and global pharmaceutical markets shift, conversations about lower-cost GLP-1 therapies are gaining momentum